How a pig heart was transplanted into a human for the first time

The first transplant of a pig heart genetically modified for acceptance into human bodies raises hopes for a new solution to donor organ shortages

Health 11 January 2022

By Clare Wilson

FOR the first time, a human has been given a transplant of a pig’s heart. David Bennett, 57, had the operation in Baltimore, Maryland, on 7 January using a heart that had been genetically modified to boost the chances of acceptance in a human body.

The donated heart came from a pig developed by US firm Revivicor. In total, the animal had 10 genes modified. Four of those were inactivated, including one that causes an aggressive immune response and one that would otherwise cause the pig’s heart to continue growing after transplant into a human body.

Pig heart is prepared for transplant

Surgeons prepare genetically engineered pig heart for transplant

University of Maryland School of Medicine

To further increase the chances of acceptance, the donor pig had six human genes inserted into its genome and Bennett is taking immune-suppressing medications. As this story went to press, Bennett was coping well with the new heart, but hadn’t yet been taken off a heart-lung bypass machine supporting its function. His medical team told The New York Times that the animal heart was doing most of the work and that, so far, the heart “looks normal”.

“This is a great step forward – you can compare it with the first landing on the moon,” says Joachim Denner at the Free University of Berlin.

Transplants from other animals, known as xenotransplantation, have long been seen as a way to save the lives of the thousands of people who die each year while waiting for an organ transplant. The chief concern is whether our immune systems will accept such transplants, as organ rejection can happen even between carefully immunologically matched human donors and recipients.

Many research groups have been trying for years to modify animals so their organs provoke less of an immune reaction, and have had success transplanting them into primates such as baboons.

These first days are a critical test, although immune rejection could take weeks or longer to develop, says Denner, who has been involved in primate research using Revivicor’s pig organs, but has no financial connection to the firm. “We have to be cautious. We have to wait and see,” he says.

Bennett was approved to have the risky procedure as he was too sick to go on the waiting list to get a human heart. If he is successfully taken off the bypass machine and continues to stay well, it could open the door to such transplants for a growing pool of other people. It could also lead to pig-to-human transplants of kidneys, livers and lungs in future.

There have been fears that virus genes naturally found in pig DNA could cross to humans, but these have faded after successful transplants of pig pancreas cells into people with diabetes. No such problems have arisen with transplants of whole pig organs into primates either. Still, it is likely that Bennett’s doctors are closely monitoring him to check for this possibility, says Anthony Warrens at Queen Mary University of London, who was not involved in the work.

“This is a very early experiment and will not translate into clinical practice within a short period of time,” he says. “If it works, it could be a small number of years away.”

If this procedure succeeds, providing the organs to offer it more widely in future shouldn’t be a major obstacle. Pigs have about eight piglets in each litter and can start breeding before they are a year old, although they would need to be farmed in special hygienic conditions.

A spokesperson for NHS Blood and Transplant in the UK said in a statement: “We have been watching this particular field of research for many years. However, there is still some way to go before transplants of this kind become an everyday reality.”

More on these topics:

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
JAL、成田-香港3月再開 ホノルルは羽田増便、成田減便 thumbnail

JAL、成田-香港3月再開 ホノルルは羽田増便、成田減便

 日本航空(JAL/JL、9201)は1月12日、羽田-ソウル(金浦)線を除く3月分の国際線運航計画を発表した。1日から冬ダイヤ最終日の26日までが対象で、運休中の成田-香港線を再開するほか、羽田-ホノルル線を増便する。また、東京発着以外の帰任需要で中部・関西行きの臨時便を設定する。 3月分の国際線運航計画を発表したJAL=PHOTO: Tadayuki YOSHIKAWA/Aviation Wire  再開・増便は3路線で、成田-香港線は週1往復で再開し、成田発を木曜、香港発を金曜に設定する。現在は現地発のみ運航する関西-ロサンゼルス線は関空発も再開。関西圏からの赴任需要に対応する。関西発は月曜、ロサンゼルス発は現在の土曜に加え、木曜発を設定する。  現在は週2往復の羽田-ホノルル線は、週3往復に増便する。火曜と金曜の羽田発は日曜を、水曜と土曜のホノルル発は月曜を、それぞれ追加する。  減便は2路線で、2月に1日1往復(週7往復)へ増便予定の成田-ホノルル線は、3月から週6往復に減便。成田発は日曜以外、ホノルル発は月曜以外運航する。現在は週3往復の羽田-ロンドン線は、ロンドン発を週1便に減便し水曜のみ運航する。羽田発は水曜と金曜、日曜の週3便を継続する。  帰任需要の臨時便は2路線で、ロンドン発関空行きを日曜のみ週1便、ダラス発中部行きは3月5日と12日に運航する。  1日3往復を計画する羽田-ソウル線は、1月29日から2月28日まで全便の運休が決まった。3月以降は未定となっている。  新型コロナウイルス前に策定した2020年度の事業計画によると、3月の冬ダイヤ期間中の国際線は未定となっているソウル線を除き、59路線3960便を計画していた。減便対象は59路線2769便で、減便率は70%となる。 *関西発着便の詳細はこちら。 関連リンク日本航空 ・JAL、関空-ロサンゼルス3月再開 帰国需要でロンドン臨時便も(22年1月13日) ・JAL赤坂社長「年度末へゆっくりした回復」地方で人材力生かす(22年1月2日) ・JAL、サーチャージ引き上げ 22年2-3月発券分(21年12月23日) ・ANA、羽田-シアトルを成田発着に バンクーバーも、3月までの国際線(21年12月14日) ・JAL、成田-ホノルル2月増便 1日1往復、北京は3月まで運休(21年12月2日)
Read More
Japanese company to deorbit big hunk of space junk by 2029 thumbnail

Japanese company to deorbit big hunk of space junk by 2029

(Image credit: Astroscale) Japanese space-sustainability company Astroscale just inked a $90 million deal to take a bus-sized rocket stage out of orbit by the end of the decade.The pioneering project, funded by the Japanese Aerospace Exploration Agency (JAXA), is a continuation of Astroscale's ADRAS-J mission, which recently completed an up-close orbital inspection of a 12-year-old
Read More
Index Of News